DealPulse Signal Wk 42: STERIS Paid $2.1 Billion for Surgical Consumables, and No Drug Made the Top Five
The top five upfronts bought pads, skincare, labs, a robot and pathology software. Three AI licences paid 3.4% upfront.
NeuroPulse
DealPulse Signal
The Beats
Analysis
The Briefs
The FTC Warned 24 Large Healthcare Companies That Following CMS Price Rules Is No Shield Against a Deception Case
One Price in Japan, Response-Linked Payments in Australia and No Public Price in China: In Asia-Pacific the Payer Sets the CAR-T Price
CMS Set December 2027 for Insurers’ Prescription Drug Price Files, a Requirement on Hold Since 2021
Only one Member State was assessing each valve when Brussels chose them, so the joint report will frame the evidence.
Korea’s First Homegrown GLP-1 Cut Weight 9.75% at 40 Weeks, So Hanmi Will Fight Wegovy and Mounjaro on Price and Supply
